- Home
- ALRN vs SLNG Comparison
ALRN vs SLNG Comparison
Compare ALRN & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- SLNG
- Stock Information
- Founded
- ALRN 2001
- SLNG 2013
- Country
- ALRN United States
- SLNG United States
- Employees
- ALRN N/A
- SLNG N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- SLNG Oil/Gas Transmission
- Sector
- ALRN Health Care
- SLNG Utilities
- Exchange
- ALRN Nasdaq
- SLNG Nasdaq
- Market Cap
- ALRN 76.9M
- SLNG 85.4M
- IPO Year
- ALRN 2017
- SLNG N/A
- Fundamental
- Price
- ALRN $1.92
- SLNG $5.46
- Analyst Decision
- ALRN Strong Buy
- SLNG
- Analyst Count
- ALRN 1
- SLNG 0
- Target Price
- ALRN $19.00
- SLNG N/A
- AVG Volume (30 Days)
- ALRN 92.8K
- SLNG 12.2K
- Earning Date
- ALRN 11-14-2024
- SLNG 11-06-2024
- Dividend Yield
- ALRN N/A
- SLNG N/A
- EPS Growth
- ALRN N/A
- SLNG N/A
- EPS
- ALRN N/A
- SLNG 0.21
- Revenue
- ALRN N/A
- SLNG $74,044,000.00
- Revenue This Year
- ALRN N/A
- SLNG N/A
- Revenue Next Year
- ALRN N/A
- SLNG N/A
- P/E Ratio
- ALRN N/A
- SLNG $27.55
- Revenue Growth
- ALRN N/A
- SLNG N/A
- 52 Week Low
- ALRN $1.61
- SLNG $3.77
- 52 Week High
- ALRN $7.42
- SLNG $6.20
- Technical
- Relative Strength Index (RSI)
- ALRN 29.69
- SLNG 54.17
- Support Level
- ALRN $1.85
- SLNG $5.41
- Resistance Level
- ALRN $2.38
- SLNG $6.20
- Average True Range (ATR)
- ALRN 0.30
- SLNG 0.36
- MACD
- ALRN -0.01
- SLNG 0.01
- Stochastic Oscillator
- ALRN 6.31
- SLNG 43.94
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About SLNG Stabilis Solutions Inc.
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.